Hims & Hers closes MedisourceRx acquisition; registers 976K shares for resale

Hims & Hers Health, Inc.

Acquisition of Seaview Enterprises LLC (MedisourceRx) closed on September 5, 2024.
976,341 shares of Class A common stock issued to Nivagen Pharmaceuticals as part of consideration.
Prospectus supplement filed on September 9, 2024 to register resale of those shares.
Purchase agreement was originally entered on July 5, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.